Plasmid delivery in vivo from porous tissue-engineering scaffolds: Transgene expression and cellular transfection

Jae Hyung Jang, Christopher B. Rives, Lonnie D. Shea

Research output: Contribution to journalArticlepeer-review

152 Citations (Scopus)


Tissue engineering scaffolds capable of sustained plasmid release can promote gene transfer locally and stimulate new tissue formation. We have investigated the scaffold design parameters that influence the extent and duration of transgene expression and have characterized the distribution of transfected cells. Porous scaffolds with encapsulated plasmid were fabricated from poly(lactide-co-glycolide) with a gas foaming procedure, with wet granulation employed to mix the components homogeneously prior to foaming. Wet granulation enhanced plasmid incorporation relative to standard procedures and also enhanced in vivo transgene expression, possibly through the increased loading and maintenance of the scaffold pore structure. The plasmid loading regulated the quantity and duration of transgene expression, with expression for 105 days achieved at the highest dosage. Expression was localized to the implantation site, though the distribution of transfected cells varied with time. Transfected cells were initially observed at the scaffold periphery (day 3), then within the pores and adjacent to the polymer (day 17), and finally throughout the scaffold interior (day 126). Delivery of a plasmid encoding VEGF increased the blood vessel density relative to control. Correlating scaffold design with gene transfer efficiency and tissue formation will facilitate application of plasmid-releasing scaffolds to multiple tissues.

Original languageEnglish
Pages (from-to)475-483
Number of pages9
JournalMolecular Therapy
Issue number3
Publication statusPublished - 2005 Sept

Bibliographical note

Funding Information:
The authors are grateful to Dixon Kaufman, Kenneth Shull, Laura De Laporte, Brian Anderson, Joanna Burdette, and Dan Gazit for technical assistance with in vivo imaging, mechanical testing, plasmids, PCNA staining, and wet granulation. Financial support for this research was provided by The Whitaker Foundation, Christopher Reeve Paralysis Foundation (SAC2-0208-2), and the NIH (R01 EB003806-01).

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Plasmid delivery in vivo from porous tissue-engineering scaffolds: Transgene expression and cellular transfection'. Together they form a unique fingerprint.

Cite this